In non-small cell lung cancer (NSCLC), ALKBH5 inhibited tumor growth and metastasis by decreasing YAP activity and regulating the miR-107/LATS2 axis in an HuR (a RNA binding protein)-dependent manner (34). Here, LATS2 is linked to non-small cell lung carcinoma.